Capio Biosciences is pleased to announce that they have received Qualified New Business Venture (QNBV) certification from WEDC. The QNBV program provides tax...

Capio Biosciences is pleased to announce receipt of an official Notice of Allowance for patent application # 10-2017-7035887 - "Method for monitoring efficac...

We are very excited that Andrew Wang MD, Assoc. Prof., Dept. of Radiation Oncology, U. of North Carolina and Cofounder of Capio Biosciences​ will be presenti...

Capio Biosciences is pleased to be recognized by StartUpCity magazine as one of the most promising 15 Biotech startups 2019, and for being at the forefront o...

Andrew Z. Wang, MD, CEO, Capio Biosciences will present "Capiocyte: A Highly Sensitive Circulating Tumor Cell Capture Assay for Improving Cancer Management"

Michael Poellmann presented "Quantification and downstream analysis of circulating tumor cells isolated using CapioCyte(TM) liquid biopsy) at the AACR annual...

Capio Biosciences "CapioCyte(TM) technology is featured in this article by John Gilmore of Genome web. https://www.genomeweb.com/cancer/circulating-tumor-cel...

Capio Biosciences, an early stage biotechnology startup company developing a biopsy-free technology for capturing Circulating Tumor Cells (CTCs) and other ta...

BUILDING A MOLECULAR DIAGNOSTICS STARTUP FROM THE GROUND UP Download PDF

Two professors at the UW–Madison School of Pharmacy’s Pharmaceutical Sciences Division are up for the challenge of being both entrepreneurs and academic rese...

Seungpyo Hong presented Enhanced Sensitivity of Specificity of Circulating Tumor Cell Capture Using a Synergistic Combination of Cell Rolling and Multivalen...

Effective Capture of Circulating Tumor Cells from a Transgenic Mouse Lung Cancer Model using Dendrimer Surfaces Immobilized with anti-EGFR Ja Hye Myung,1 Mon...

Seungpyo Hong, founder of the cancer diagnostic company and Madison startup Capio Biosciences, said he met with executives from Foxconn recently and was hope...

Jeff Buchanan | January 5th, 2017 In certain patients who are being treated for cancer, it’s possible for cells to detach from the tumors inside their bodies...

by Judy Newman | Wisconsin State Journal | Dec 31, 2016 Madison draws a startup from Chicago with a novel way to track cancer Judy Newman | Wisconsin State...

A start-up company co-founded by UNC Lineberger researcher Andrew Wang, MD, has raised $2.9 million to commercialize a test designed to capture cancer cells ...